| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/24/2006 | US20060189652 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; reacting nitrogen heterocyclic compound with carbonylation agent selected from phosgene, diphosgene, triphosgene, aryl chloroformates, aralkyl chloroformates, alkyl chloroformates, cyclization |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189615 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 08/24/2006 | US20060189609 1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 08/24/2006 | US20060189598 substituted azole acid derivatives which modulate blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid levels; hypolipidemic agent; hyperglycemia, hyperinsulinemia, hyperlipidemia, obesity, atherosclerosis; Type 2 diabetes |
| 08/24/2006 | US20060189591 Five-membered heterocyclic derivative |
| 08/24/2006 | US20060189589 For therapy of Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease |
| 08/24/2006 | US20060189584 Pharmaceutical combinations |
| 08/24/2006 | US20060189578 Method for the synthesis of compounds of formula I and their uses thereof |
| 08/24/2006 | US20060189575 Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels |
| 08/24/2006 | US20060189567 Compound having affinity with calcified tissue |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | US20060189525 DADD, death activator death domain protein |
| 08/24/2006 | US20060189483 Metal-containing compositions, preparations and uses |
| 08/24/2006 | US20060188560 Delivery system for nucleic acids |
| 08/24/2006 | US20060188534 Dispersions for the formulation of slightly or poorly soluble agents |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | DE10150824B4 Konzentrat, seine Herstellung und Verwendung Concentrate, its preparation and use |
| 08/24/2006 | DE10040742B4 Mittel zur Herz-Kreislauf-Protektion Means for cardiovascular-protection |
| 08/24/2006 | CA2598988A1 Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing the same as nhe inhibitors |
| 08/24/2006 | CA2598159A1 Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury |
| 08/24/2006 | CA2597498A1 Therapeutic combinations of manidi pine and a statin |
| 08/24/2006 | CA2597269A1 1-substituted-7-(beta-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 08/24/2006 | CA2596922A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
| 08/24/2006 | CA2596768A1 A method for treating heart failure |
| 08/23/2006 | EP1693456A1 Gene encoding g protein-coupled receptor and gene product thereof |
| 08/23/2006 | EP1693451A1 Method of growing myocardial cells |
| 08/23/2006 | EP1693376A2 Crystalline composites comprising phytosterols and phytostanols or derivatives thereof |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1693367A1 Piperidine compound and method for producing same |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1693065A1 Fibroblast-mobilizing agent containing g-csf and wound remedy |
| 08/23/2006 | EP1693060A1 Therapeutic or preventive agents for ischemic neuropathy |
| 08/23/2006 | EP1693052A1 Compositions for delivery of drug combinations |
| 08/23/2006 | EP1692305A1 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1692133A1 Diazabicyclononene derivatives and their use as renin inhibitors |
| 08/23/2006 | EP1692132A2 Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain |
| 08/23/2006 | EP1691891A2 Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure |
| 08/23/2006 | EP1691827A1 Use of peptides derived from the alpha or beta chain of human fibronogen for the treatment of shock |
| 08/23/2006 | EP1691804A1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
| 08/23/2006 | EP1633346B1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid|- 2- (phenyl)- amid| derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 08/23/2006 | EP1558612B1 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 08/23/2006 | EP1534271B1 Antitumor compound and therapeutic uses thereof |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | EP1369489B1 Flavonoid compound and process for producing the same |
| 08/23/2006 | EP1332144B1 Indole derivatives as pde5-inhibitors |
| 08/23/2006 | EP1324981B1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 08/23/2006 | EP1315537B1 System for myocardial infarction repair |
| 08/23/2006 | EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 08/23/2006 | EP1278716B1 Trans-n-¬4-(4-hydroxyphenyl)cyclohexyl|-3-phenylpropionamide as subtype selective nmda receptor antagonist |
| 08/23/2006 | EP1261330B1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
| 08/23/2006 | EP1223929B1 Cannabimimetic indole derivatives |
| 08/23/2006 | EP1146870B1 Antioxidant compositions for companion animals |
| 08/23/2006 | EP1051405B1 Novel dihydroxyhexanoic acid derivatives |
| 08/23/2006 | EP0800514B1 Substituted imides as tnf inhibitors |
| 08/23/2006 | CN1823076A Silicon compounds and their use |
| 08/23/2006 | CN1823071A Thienopyrimidine derivatives as potassium channel inhibitors |
| 08/23/2006 | CN1823041A 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 08/23/2006 | CN1822879A Use of whey permeate for the treatment of metabolic syndrome |
| 08/23/2006 | CN1822846A Perivascular mesenchymal precursor cell induced blood vessel formation |
| 08/23/2006 | CN1822845A Means for preventing and treating cellular death and their biological applications |
| 08/23/2006 | CN1822833A Use of 3,7-diazabicyclo not 3,3,1|nonane compounds for the treatment and/or prophylaxis of arrhythmic events in male human patients |
| 08/23/2006 | CN1822817A Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 08/23/2006 | CN1821242A Novel method for preparing dihydroxy acid HMG CoA reductase inhibitor |
| 08/23/2006 | CN1820770A Chinese medicine composition for treating apoplexy and its preparing method |
| 08/23/2006 | CN1820751A Tirofiban powder injection and its preparing method |
| 08/23/2006 | CN1820742A Medicinal Composition of ferulate and chuanxiongqine salt |
| 08/23/2006 | CN1820616A Biological health tea |
| 08/23/2006 | CN1271083C Composition, extraction process and use of total triterpene sapogenin extracted from bamboo |
| 08/23/2006 | CN1271070C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 08/23/2006 | CN1271068C Novel method for preparing olmesartan |
| 08/23/2006 | CN1270777C Addition agent of pyrithioxine hydrochloride utilized for injection |
| 08/23/2006 | CN1270767C Medicine for treating vasculitis, scleriasis and arteriosclerosis type lower limb vascular occlusion |
| 08/23/2006 | CN1270756C Capsules for hypertension and its preparation |
| 08/23/2006 | CN1270747C Quick-acting hemorrhoid treating ointment |
| 08/23/2006 | CN1270740C Ready prepared Chinese medicine for treating angeitis and preparation process |
| 08/23/2006 | CN1270739C Freeze drying powder containing red ginseng and method for preparing the same |
| 08/23/2006 | CN1270721C Rapid disintegration and rapid dissolution tablet containing kakonein |
| 08/23/2006 | CN1270720C Yolk lecithin for injection and method for making same |
| 08/23/2006 | CN1270712C Felodipine controlled-release preparation |
| 08/23/2006 | CN1270711C Aminochlorodipin, irbesartan compound preparation |
| 08/23/2006 | CN1270707C Ophthalmic solution |
| 08/23/2006 | CN1270703C Sustained release preparation of phenoprolamine hydrochloride and its preparing process |
| 08/23/2006 | CN1270702C Intravenous injection liquid of coenzyme Q10, and its prepn. method |
| 08/23/2006 | CN1270699C 'Shengmai' injection and its preparation process |
| 08/23/2006 | CN1270634C Soft capsule of dried oviduct fat of forest frog |
| 08/22/2006 | US7094903 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 08/22/2006 | US7094802 PKB-3564 substance with neovascularization inhibitory activity |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094797 Organ fibrosis inhibitor |
| 08/22/2006 | US7094783 Inhibitors of serine proteases; for therapy of thromboembolic disorder |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/22/2006 | US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets |
| 08/22/2006 | US7094772 Phosphonate compounds |
| 08/22/2006 | US7094549 mass spectroscopy; medical diagnosis/prognosis; kits |
| 08/17/2006 | WO2006086500A2 Compositions and methods for treating vascular, autoimmune and inflammatory diseases |
| 08/17/2006 | WO2006086498A2 Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors |